Archives

Beckman Coulter Connects Scopio Labs Digital Cell Morphology with Hematology Workcell Extending Automated Workflow

Beckman Coulter

Beckman Coulter, a global leader in clinical diagnostics, announced it will debut its hematology analyzer and slidemaker stainer connected to Scopio Labs’ digital morphology platform for end-to-end digitization with artificial intelligence-assisted peripheral blood smear analysis at the 2023 American Association for Clinical Chemistry (AACC) Annual Scientific Meeting and Clinical Lab Expo. The solution features the Beckman Coulter DxH 900 Workcell and DxH Slidemaker Stainer II connected with the Scopio X100HT digital morphology platform capable of continuous loading, scanning and analysis.

“With the increasing attention of hematological disorders and malignancies, the accuracy and timeliness of peripheral blood smears results are critically important for timely diagnosis and effective treatment initiation,” said Dan Xu, Vice President/GM, Hematology and Urinalysis Business Units for Beckman Coulter. “The peripheral blood smear (PBS) review is a powerful diagnostic tool that provides clinicians with information about a variety of disorders such as blood-related cancers, anemia, infections, and many other life-threatening medical conditions. Often, performing PBS analysis forces medical technicians to compromise on either field of view or resolution and requires physically transferring PBS slides to a microscope for manual review. Our new capability to automatically transfer PBS slides from Beckman Coulter‘s DxH Slidemaker Stainer II to the Scopio X100HT platform removes the need for a technician to manually transfer the slides, resulting in lab efficiency for medical technicians, while Scopio’s Full-Field technology removes the need to revert to the microscope for manual review.”

Also Read: Sas and thread launch proprietary offering for biopharma companies 

“Connecting the Scopio X100HT with the DxH 900 Workcell is a tremendous step forward in advancing our global partnership with Beckman Coulter, which we initiated one year ago,” said Itai Hayut, CEO and Co-Founder of Scopio Labs. “A fully integrated hematology workflow from the complete blood count (CBC) test to slide staining (SMS) to peripheral blood smears (PBS) will empower qualified experts in detecting blood-related medical conditions.”

In manual microscopy, users must choose between a large field of view or high resolution. Scopio solves that trade-off, capturing large scan areas at 100X magnification, and virtually eliminates the need for additional manual microscopic examination. With this newly connected capability, the X100HT is able to process up to 30 samples an hour, meeting the high-throughput requirements of large hospitals and labs, and fully supports remote review capabilities.

SOURCE: PRNewswire